Expanding the phenotype of DNMT3A as a cause a congenital myopathy with rhabdomyolysis.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
06 2023
Historique:
received: 17 12 2022
revised: 17 02 2023
accepted: 03 04 2023
medline: 31 7 2023
pubmed: 21 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

Pathogenic variants in DNMT3A are most commonly associated with Tatton-Brown-Rahman Syndrome (TBRS), but includes other phenotypes such as Heyn-Sproul-Jackson syndrome and acute myeloid leukemia (AML). We describe a patient presenting to the neuromuscular clinic with a de novo missense variant in DNMT3A where the striking clinical feature is that of a congenital myopathy with associated episodes of rhabdomyolysis, severe myalgias and chest pain along with phenotypic features associated with TBRS. Muscle biopsy showed minor myopathic features and cardiac investigations revealed mildly impaired bi-ventricular systolic function. We confirmed the DNA methylation profile matched haplo-insufficient TBRS cases, consistent with a loss of methyltransferase activity. Our report emphasizes the phenotypic overlap of patients with syndromic disorders presenting to neuromuscular clinics and limitations of gene panels in establishing a molecular diagnosis.

Identifiants

pubmed: 37209493
pii: S0960-8966(23)00099-8
doi: 10.1016/j.nmd.2023.04.002
pii:
doi:

Substances chimiques

DNA (Cytosine-5-)-Methyltransferases EC 2.1.1.37
DNA Methyltransferase 3A EC 2.1.1.37

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-489

Informations de copyright

Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Roula Ghaoui (R)

Department of Neurology, Royal Adelaide Hospital, South Australia, Australia; Adelaide Medical School, The University of Adelaide, South Australia, Australia; Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia. Electronic address: roula.ghaoui@sa.gov.au.

Thuong T Ha (TT)

Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia; ACRF Genomics Facility, Centre for Cancer Biology, An alliance between SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.

Jennifer Kerkhof (J)

Verspeeten Clinical Genome Centre at London Health Sciences Centre, Ontario, Canada.

Haley McConkey (H)

Verspeeten Clinical Genome Centre at London Health Sciences Centre, Ontario, Canada.

Song Gao (S)

Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.

Milena Babic (M)

Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.

Rob King (R)

Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.

Gianina Ravenscroft (G)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia; School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.

Barbara Koszyca (B)

Department of Anatomical Pathology, SA Pathology, South Australia 5000, Australia.

Sophia Otto (S)

Department of Anatomical Pathology, SA Pathology, South Australia 5000, Australia.

Nigel G Laing (NG)

Centre for Medical Research University of Western Australia, Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, Western Australia, Australia.

Hamish Scott (H)

Adelaide Medical School, The University of Adelaide, South Australia, Australia; Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia; ACRF Genomics Facility, Centre for Cancer Biology, An alliance between SA Pathology and the University of South Australia, Adelaide, South Australia, Australia; Australian Genomics, Victoria, Australia.

Bekim Sadikovic (B)

Verspeeten Clinical Genome Centre at London Health Sciences Centre, Ontario, Canada; Department of Pathology and Laboratory Medicine and Department of Pediatrics, Western University, Ontario, Canada.

Karin S Kassahn (KS)

Adelaide Medical School, The University of Adelaide, South Australia, Australia; Department of Genetics & Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH